Agios Pharmaceuticals, Inc. (AGIO)
28.18
+0.18
(+0.62%)
USD |
NASDAQ |
May 01, 16:00
28.18
0.00 (0.00%)
After-Hours: 17:19
Agios Pharmaceuticals Total Assets (Quarterly) : 1.185B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Biogen, Inc. | 29.48B |
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Apellis Pharmaceuticals, Inc. | 1.075B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 75.88M |
| Shareholders Equity (Quarterly) | 1.109B |
| Debt to Equity Ratio | 0.0322 |
| Current Ratio | 14.19 |
| Net Debt Paydown Yield | 0.21% |